Hong Kong · Delayed Price · Currency is HKD Essex Bio-Technology Statistics
Total Valuation
HKG:1061 has a market cap or net worth of HKD 1.89 billion. The enterprise value is 1.45 billion.
| Market Cap | 1.89B |
| Enterprise Value | 1.45B |
Important Dates
The last earnings date was Monday, March 23, 2026.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
HKG:1061 has 567.01 million shares outstanding. The number of shares has decreased by -2.63% in one year.
| Current Share Class | 567.01M |
| Shares Outstanding | 567.01M |
| Shares Change (YoY) | -2.63% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 54.08% |
| Owned by Institutions (%) | 1.57% |
| Float | 260.38M |
Valuation Ratios
The trailing PE ratio is 5.94 and the forward PE ratio is 5.84.
| PE Ratio | 5.94 |
| Forward PE | 5.84 |
| PS Ratio | 1.04 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | 9.50 |
| P/OCF Ratio | 6.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.06, with an EV/FCF ratio of 7.30.
| EV / Earnings | 4.56 |
| EV / Sales | 0.80 |
| EV / EBITDA | 3.06 |
| EV / EBIT | 3.48 |
| EV / FCF | 7.30 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.11 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | 1.74 |
| Interest Coverage | 53.33 |
Financial Efficiency
Return on equity (ROE) is 14.02% and return on invested capital (ROIC) is 16.18%.
| Return on Equity (ROE) | 14.02% |
| Return on Assets (ROA) | 8.05% |
| Return on Invested Capital (ROIC) | 16.18% |
| Return on Capital Employed (ROCE) | 15.30% |
| Weighted Average Cost of Capital (WACC) | 3.95% |
| Revenue Per Employee | 1.41M |
| Profits Per Employee | 246,774 |
| Employee Count | 1,426 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, HKG:1061 has paid 96.57 million in taxes.
| Income Tax | 96.57M |
| Effective Tax Rate | 23.29% |
Stock Price Statistics
The stock price has decreased by -27.29% in the last 52 weeks. The beta is 0.02, so HKG:1061's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -27.29% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 4.47 |
| Relative Strength Index (RSI) | 40.09 |
| Average Volume (20 Days) | 471,850 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1061 had revenue of HKD 1.81 billion and earned 318.09 million in profits. Earnings per share was 0.56.
| Revenue | 1.81B |
| Gross Profit | 1.62B |
| Operating Income | 416.78M |
| Pretax Income | 414.66M |
| Net Income | 318.09M |
| EBITDA | 467.90M |
| EBIT | 416.78M |
| Earnings Per Share (EPS) | 0.56 |
Balance Sheet
The company has 784.14 million in cash and 346.90 million in debt, with a net cash position of 437.24 million or 0.77 per share.
| Cash & Cash Equivalents | 784.14M |
| Total Debt | 346.90M |
| Net Cash | 437.24M |
| Net Cash Per Share | 0.77 |
| Equity (Book Value) | 2.41B |
| Book Value Per Share | 4.26 |
| Working Capital | 853.22M |
Cash Flow
In the last 12 months, operating cash flow was 306.32 million and capital expenditures -107.51 million, giving a free cash flow of 198.81 million.
| Operating Cash Flow | 306.32M |
| Capital Expenditures | -107.51M |
| Depreciation & Amortization | 51.12M |
| Net Borrowing | 144.43M |
| Free Cash Flow | 198.81M |
| FCF Per Share | 0.35 |
Margins
Gross margin is 89.20%, with operating and profit margins of 22.98% and 17.54%.
| Gross Margin | 89.20% |
| Operating Margin | 22.98% |
| Pretax Margin | 22.86% |
| Profit Margin | 17.54% |
| EBITDA Margin | 25.80% |
| EBIT Margin | 22.98% |
| FCF Margin | 10.96% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 4.33%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 4.33% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 23.17% |
| Buyback Yield | 2.63% |
| Shareholder Yield | 6.88% |
| Earnings Yield | 16.85% |
| FCF Yield | 10.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1061 has an Altman Z-Score of 3.54 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 5 |